Jane Street Group, LLC Evotec Se Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$8.95 - $12.48 $323,972 - $451,751	-36,198 Reduced 66.41%	18,310 $206,000
Q1 2023 May 15, 2023	SELL	$8.11 - $10.53 $137,148 - $178,072	-16,911 Reduced 23.68%	54,508 $569,000
Q4 2022 Feb 14, 2023	BUY	$7.8 - $9.85 $55,801 - $70,466	7,154 Added 11.13%	71,419 $577,000
Q3 2022 Nov 14, 2022	SELL	$8.4 - $28.4 $353,304 - $1.19 Million	-42,060 Reduced 39.56%	64,265 $565,000
Q3 2022 Nov 14, 2022	SELL	$8.4 - $28.4 $353,304 - $1.19 Million	-42,060 Reduced 39.56%	64,265 $565,000
Q2 2022 Aug 16, 2022	SELL	$10.78 - $15.5 $228,611 - $328,708	-21,207 Reduced 16.63%	106,325 $1.28 Million
Q1 2022 May 17, 2022	BUY	$12.93 - $23.46 $916,090 - $1.66 Million	70,850 Added 125.0%	127,532 $1.93 Million
Q4 2021 Feb 15, 2022	BUY	$22.0 - $25.77 $1.25 Million - $1.46 Million	56,682 New	56,682 $1.37 Million

2.86M

Ticker EVO
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 353,904,992
Market Cap $1.62B
Description
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.